Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Vicept Buy, Allergan Gains Rosacea Treatment Under Development

Executive Summary

Drug firm Allergan Inc. has a daily rosacea treatment in the development pipeline following its acquisition of privately held specialty biopharmaceutical firm Vicept Therapeutics in July.
Advertisement

Related Content

AcneFree Purchase Builds U.S. Scale For Canadian Dermatology Firm
Deals Of The Week: Eisai/Epizyme, AstraZeneca/Galderma, Evotec/Harvard
Deals Of The Week: Eisai/Epizyme, AstraZeneca/Galderma, Evotec/Harvard
GSK Gains Foothold In U.S. Skin Care With Stiefel Deal
Advertisement
UsernamePublicRestriction

Register

RS017711

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel